Summary of BIO-key International (BKYI) Q2 2026 Earnings Call

1Key Financial Results and Metrics

Revenue: Q2 2026 revenue increased by 13% to $1.92 million, up from $1.7 million in Q2 2025. For the first half of 2026, revenue grew 23%.

License Fee Revenue: Rose 53% to $1.2 million, driven by new customer agreements.

Hardware Revenue: Decreased by 19% to $460,000 due to delayed shipments of a large order.

Gross Profit: Increased by 36% to $1.7 million, with gross margin improving to 87% from 73% a year ago.

Net Loss: Improved significantly by 51% to $577,000 ($0.56 per share) compared to a net loss of $1.17 million ($2.10 per share) in Q2 2025. The first half loss improved by 59% to $782,000 ($0.75 per share).

Cash Position: Post-quarter, cash increased to over $4.5 million, bolstered by a $2.5 million warrant transaction.

2Strategic Updates and Business Highlights

Market Momentum: Strong demand for authentication solutions, particularly in EMEA, with new partnerships and project discussions accelerating.

Product Development: The PortalGuard 7.0 platform upgrade is being rolled out, enhancing the product offering.

Partnerships: Notable partnerships include MaktabiTech for Saudi Arabia's educational sector and the Central Bank of Jordan for national financial sector modernization.

Biometric Solutions: The company is focusing on the role of biometric authentication in securing AI ecosystems, which is seen as a significant growth opportunity.

3Forward Guidance and Outlook

Growth Expectations: Management anticipates continued growth and is targeting profitability for the second half of 2026, despite the delayed hardware order.

Pipeline Strength: A robust pipeline in EMEA across various sectors (government, defense, financial services, education) is expected to drive future revenue.

Market Potential: The global market for authentication solutions is projected to grow from $26 billion to over $114 billion by 2036, presenting a significant opportunity for BIO-key.

4Bad News, Challenges, or Points of Concern

Delayed Hardware Orders: The postponement of a significant hardware order impacted Q2 results and could affect revenue recognition in the near term.

Market Volatility: The stock price has faced pressure, attributed to broader market trends affecting small-cap companies, despite positive earnings announcements.

Competitive Landscape: There are concerns regarding competition from larger firms like Microsoft and Google, which may limit market share growth.

5Notable Q&A Insights

Hardware Order Visibility: Management indicated uncertainty about the timing of the delayed hardware order, but expressed optimism about other large contracts in the pipeline.

License Revenue Growth: Despite historical slowdowns in Q3, management expects continued growth across all segments, including license revenue.

Cash Utilization: The raised capital will support operations and growth initiatives, with no further dilution expected.

Jordan Initiative: The Central Bank of Jordan's project is beyond the pilot stage and is expected to generate significant revenue in the coming quarters.

AI and Biometrics: The potential for biometrics in AI governance is highlighted as a critical area for future development, with ongoing evaluations and pilots with large customers. This summary captures the essential aspects of BIO-key's Q2 2026 earnings call, providing a balanced view of the company's performance, strategic direction, and challenges ahead.